Abstract:Atractylenolides, comprising atractylenolide I, II, and III, represent the principal bioactive constituents of Atractylodes macrocephala, a traditional Chinese medicine. These compounds exhibit a diverse array of pharmacological properties, including anti-inflammatory, anti-cancer, and organ-protective effects, underscoring their potential for future research and development. Recent investigations have demonstrated that the anti-cancer activity of the three atractylenolides can be attributed to their influence on the JAK2/STAT3 signaling pathway. Additionally, the TLR4/NF-κB, PI3K/Akt, and MAPK signaling pathways primarily mediate the anti-inflammatory effects of these compounds. Atractylenolides can protect multiple organs by modulating oxidative stress, attenuating the inflammatory response, activating anti-apoptotic signaling pathways, and inhibiting cell apoptosis. These protective effects extend to the heart, liver, lung, kidney, stomach, intestine, and nervous system. Consequently, atractylenolides may emerge as clinically relevant multi-organ protective agents in the future. Notably, the pharmacological activities of the three atractylenolides differ. Atractylenolide I and III demonstrate potent anti-inflammatory and organ-protective properties, whereas the effects of atractylenolide II are infrequently reported. This review systematically examines the literature on atractylenolides published in recent years, with a primary emphasis on their pharmacological properties, in order to inform future development and application efforts.

A New 9-nor-atractylodin from Atractylodes Lancea and the Antibacterial Activity of the Atractylodin Derivatives

Phytochemical and chemotaxonomic study on Atractylodes lancea

Two Novel Sesquiterpenoid Glycosides from the Rhizomes of Atractylodes lancea

Two new sesterterpenoids from Atractylodes japonica Koidz. ex Kitam

Diverse Sesquiterpenoids and Polyacetylenes from Atractylodes lancea and Their Anti-Osteoclastogenesis Activity

Alokicenones A-H, Eight Tetrahydroanthracenes from the Mangrove-Derived Streptomyces Sp. HN-A101

(±)‐Atrachinenins A—C, Three Pairs of Caged C 27 Meroterpenoids from the Rhizomes of Atractylodes chinensis

Lancolides, antiplatelet aggregation nortriterpenoids with tricyclo[6.3.0.02,11]undecane-bridged system from Schisandra lancifolia

Atramacrolodes A‐D (1‐4), Four Undescribed Eudesmane‐type Sesquiterpenes from the Rhizome of Atractylodes macrocephala

Studies on constituents and anti-inflammatory activity of rhizoma Atractylodis macrocephalae

Four New Eudesmane-Type Sesquiterpenoid Lactones from Atractylenolide II by Biotransformation of Rat Hepatic Microsomes

Atrachinenynes A–D, four diacetylenic derivatives with unprecedented skeletons from the rhizomes of Atractylodes chinensis

A new diterpenoid alkaloid with antimicrobial activity from Aconitum brachypodum Diels.

New Eudesmane-Type Sesquiterpenoids From The Processed Rhizomes Of Atractylodes Macrocephala

A new pentacyclic triterpenoid from the leaves of Rhododendron dauricum L. with inhibition of NO production in LPS-induced RAW 264.7 cells

Chemical Constitution, Pharmacological Effects and the Underlying Mechanism of Atractylenolides: A Review

Secondary metabolites from the endophytic fungus Letendraea helminthicola A820 with Anti‐inflammatory activity

Synthesis and Cytotoxic Activity of Derivatives of 24-NOR-Lupane-Triterpenoid Acids Isolated from Acanthopanax trifoliatus

Structural investigation and biological activity of sesquiterpene lactones from the traditional Chinese herb Inula racemosa.

Two new guaiane-type sesquiterpene glycosides from Atractylodes Japonica Koidz. ex Kitam

Four new sesquiterpene lactones from Atractylodes macrocephala and their CREB agonistic activities